-
Establishment and characterization of circulating tumor cells-derived organoids from metastatic breast cancer patients.
Study
EGAS00001007582
-
Genomic landscape of oral cancers (Illumina WGS)
Study
EGAS00001003228
-
Characterization of alternative promoter usage in advanced prostate cancer
Study
EGAS00001006275
-
The impact of mutational clonality in predicting the response to anti-PD-L1/PD-L1 in advanced urothelial cancer
Study
EGAS00001007086
-
Prospective high-throughput genome profiling in advanced cancers:
Study
EGAS00001004554
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__Oesophageal_adenocarcinoma
Study
EGAS00001003702
-
Myeloproliferative_Disease_Whole_Genomes
Study
EGAS00001000290
-
Transcriptional_analysis_of_cells_from_lungs
Study
EGAS00001002649
-
Surgery in combination with immune checkpoint therapy as an effective treatment for patients with metastatic cancer.
Study
EGAS00001005667
-
Non-small cell lung cancer sequencing
Study
EGAS00001005499
-
Copy number and mutation profiling of Stage 1 epithelial ovarian cancer biopsies
Study
EGAS00001004961
-
Drug-induced epigenomic plasticity reprograms circadian rhythm regulation to drive prostate cancer towards androgen-independence (RNA-seq)
Study
EGAS00001006016
-
Triple_Negative_Breast_Cancer_Whole_Genomes
Study
EGAS00001000092
-
Breast_Cancer_Somatic_Genetics_Study_
Study
EGAS00001000195
-
HER2_positive_Breast_Cancer_
Study
EGAS00001000042
-
Matched_breast_cancer_fusion_gene_study
Study
EGAS00001000031
-
Xenograft_Sequencing
Study
EGAS00001000140
-
Triple_Negative_Breast_Cancer_RNA_Sequencing
Study
EGAS00001000377
-
BASIS_RNAseq
Study
EGAS00001000707
-
An Isogenic Cell Line Panel for Sequence-based Screening of Targeted Anti-cancer Drugs
Study
EGAS00001005974
-
Metabolic profiling of patient-derived organoids reveals nucleotide synthesis as a metabolic vulnerability in malignant rhabdoid tumors
Study
EGAS00001007877
-
Aggressive PDACs show hypomethylation of repetitive elements and the execution of an intrinsic IFN program linked to a ductal cell-of-origin
Study
EGAS00001004660
-
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer
Study
EGAS00001005984
-
Copy-number signatures and mutational processes in ovarian carcinoma
Study
EGAS00001002557
-
Spatial atlas of clonal copy number alterations in co-existing benign and malignant tissue
Study
EGAS00001006124